Matches in Nanopublications for { ?s ?p "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP921354.RAfj-PYn0tRcQ_ZqhkHVagodKJ-iNnFcYfYgd-pQ-QZLE130_assertion description "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921354.RAfj-PYn0tRcQ_ZqhkHVagodKJ-iNnFcYfYgd-pQ-QZLE130_provenance.
- NP884214.RAuKxv-q5a41lewAtrJn6Ia4SvuynGhWm7uvNoH8nPjFw130_assertion description "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884214.RAuKxv-q5a41lewAtrJn6Ia4SvuynGhWm7uvNoH8nPjFw130_provenance.
- NP342119.RAAjGUAnCygy7y1oo2XZNiaTf889rnVnXZkfzJC8Ua89g130_assertion description "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342119.RAAjGUAnCygy7y1oo2XZNiaTf889rnVnXZkfzJC8Ua89g130_provenance.
- assertion description "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1376355.RAkLnI4cs5fL6a0sX_hg-xdFWUF0d1pmdA3T8DkUioOjQ130_assertion description "[Relative to subjects with an inactivating allele, those with an additional copy of the CYP2D6 gene and no inactivating alleles may be at increased risk of lung cancer, particularly for adenocarcinoma (OR = 3.61, 95% CI 1.08-11.7 for African-Americans and OR = 2.20, 95% CI 0.69-6.0 for Caucasians).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1376355.RAkLnI4cs5fL6a0sX_hg-xdFWUF0d1pmdA3T8DkUioOjQ130_provenance.